| Clinical data | |
|---|---|
| Trade names | Aducin, Becantal, Becantex, Bechisan, Bexedyl, Keuten, Linctussal, Pectoro |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.035.511 |
| Chemical and physical data | |
| Formula | C18H24O3S |
| Molar mass | 320.45 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
Dibunate is acough suppressant.[1] As the sodium salt, it has been marketed under the name Becantyl (in the United Kingdom), Becantex (in continental Europe), or Linctussal with a dosage of 20 to 30 mg, as either syrup or tablets.[2]
Similar tobenzonatate, it is a peripherally acting drug. It has not been reported to cause sedation, euphoria, habituation, orrespiratory depression, unlike narcotic antitussives such ascodeine. It may work by blocking afferent signals in thereflex arc which controls cough.[3] Nausea is rarely seen as an adverse effect.[4]
Thisdrug article relating to therespiratory system is astub. You can help Wikipedia byexpanding it. |